References
- Tuerk, C. and L. Gold (1990) Systematic evolution of ligands by expenential enrichment: RNA ligands to bicteriophage T4 DNA polymerase. Science 249: 505-510. https://doi.org/10.1126/science.2200121
- Ellington, A. D. and J. W. Szostak (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822. https://doi.org/10.1038/346818a0
-
Ciesiolka, J., J. Gorski, and M. Yarus (1995) Selection of an RNA domain that binds
$Zn^{2+}$ . RNA 1: 538-550. - Ma, C., H. Huang, and C. Zhao (2010) An aptamer-based and pyrene-labeled fluorescent biosensor for homogeneous detection of potassium ions. Anal. Sci. 26: 1261-1264. https://doi.org/10.2116/analsci.26.1261
- Sassanfar, M. and J. W. Szostak (1993) An RNA motif that binds ATP. Nature 364: 550-553. https://doi.org/10.1038/364550a0
- Huizenga, D. E. and J. W. Szostak (1995) A DNA aptamer that binds adenosine and ATP. Biochemistry 34: 656-665. https://doi.org/10.1021/bi00002a033
- Kraus, E., W. James, and A. N. Barclay (1998) Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J. Immunol. 160:5209-5212.
- Feng, L., Y. Chen, J. Ren, and X. Qu (2011) A graphene functionalized electrochemical aptasensor for selective labelfree detection of cancer cells. Biomaterials 32: 2930-2937. https://doi.org/10.1016/j.biomaterials.2011.01.002
- Shi, H., X. He, K. Wang, X. Wu, X. Ye, Q. Guo, W. Tan, Z. Qing, X. Yang, and B. Zhou (2011) Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc.Natl. Acad. Sci. USA 108: 3900-3905. https://doi.org/10.1073/pnas.1016197108
- Compton, C., C. M. Fenoglio-Preiser, N. Pettigrew, and L. P. Fielding (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88: 1739-1757. https://doi.org/10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T
- Thompson, I. M., D. K. Pauler, P. J. Goodman, C. M. Tangen, M. S. Lucia, H. L. Parnes, L. M. Minasian, L. G. Ford, S. M. Lippman, E. D. Crawford, J. J. Crowley, and C. A. Jr. Coltman (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N. Engl. J. Med. 350: 2239-2246. https://doi.org/10.1056/NEJMoa031918
- Collas, P. (2010) The current state of chromatin immunoprecipitation. Mol. Biotechnol. 45: 87-100. https://doi.org/10.1007/s12033-009-9239-8
- O'Neill, L. P. and B. M. Turner (1996) Immunoprecipitation of chromatin. Methods Enzymol. 274: 189-197. https://doi.org/10.1016/S0076-6879(96)74017-X
- Bock, L. C., L. C. Griffin, J. A. Latham, E. H. Vermaas, and J. J. Toole (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355: 564-566. https://doi.org/10.1038/355564a0
- Paborsky, L. R., S. N. McCurdy, L. C. Griffin, J. J. Toole, and L. L. Leung (1993) The single-stranded DNA aptamer-binding site of human thrombin. J. Biol. Chem. 268: 20808-20811.